OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $2,165,060 Invested

2023

Life Molecular Imaging, Ltd

Andrew Stephens, MD, Ph.D

PET imaging activated astrocytes in Alzheimer's Disease continuum with [18F]F-DED

  • Funding Amount: $2,165,060
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Neuroinflammation
  • Status: Active